BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 29455656)

  • 1. The E3 ubiquitin ligase NEDD4 mediates cell migration signaling of EGFR in lung cancer cells.
    Shao G; Wang R; Sun A; Wei J; Peng K; Dai Q; Yang W; Lin Q
    Mol Cancer; 2018 Feb; 17(1):24. PubMed ID: 29455656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of Neural Precursor Cell Expressed Developmentally Downregulated 4-1 is Associated with Poor Prognosis and Chemoresistance in Lung Adenocarcinoma.
    Song YH; Zhang CQ; Chen FF; Lin XY
    Chin Med J (Engl); 2018 Jan; 131(1):16-24. PubMed ID: 29271375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HECT E3 ubiquitin ligase Nedd4-1 ubiquitinates ACK and regulates epidermal growth factor (EGF)-induced degradation of EGF receptor and ACK.
    Lin Q; Wang J; Childress C; Sudol M; Carey DJ; Yang W
    Mol Cell Biol; 2010 Mar; 30(6):1541-54. PubMed ID: 20086093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An outlined review for the role of Nedd4-1 and Nedd4-2 in lung disorders.
    He H; Huang C; Chen Z; Huang H; Wang X; Chen J
    Biomed Pharmacother; 2020 May; 125():109983. PubMed ID: 32092816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E3 ubiquitin ligase NEDD4 is translationally upregulated and facilitates pancreatic cancer.
    Weng M; Luo ZL; Wu XL; Zeng WZ
    Oncotarget; 2017 Mar; 8(12):20288-20296. PubMed ID: 28423617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.
    Tumur Z; Katebzadeh S; Guerra C; Bhushan L; Alkam T; Henson BS
    Neoplasia; 2015 Jan; 17(1):141-51. PubMed ID: 25622907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NEDD4-induced degradative ubiquitination of phosphatidylinositol 4-phosphate 5-kinase α and its implication in breast cancer cell proliferation.
    Tran MH; Seo E; Min S; Nguyen QT; Choi J; Lee UJ; Hong SS; Kang H; Mansukhani A; Jou I; Lee SY
    J Cell Mol Med; 2018 Sep; 22(9):4117-4129. PubMed ID: 29851245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I γ Phosphatidylinositol Phosphate 5-Kinase i5 Controls the Ubiquitination and Degradation of the Tumor Suppressor Mitogen-inducible Gene 6.
    Sun M; Cai J; Anderson RA; Sun Y
    J Biol Chem; 2016 Oct; 291(41):21461-21473. PubMed ID: 27557663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas.
    Amodio N; Scrima M; Palaia L; Salman AN; Quintiero A; Franco R; Botti G; Pirozzi P; Rocco G; De Rosa N; Viglietto G
    Am J Pathol; 2010 Nov; 177(5):2622-34. PubMed ID: 20889565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NEDD4 is overexpressed in colorectal cancer and promotes colonic cell growth independently of the PI3K/PTEN/AKT pathway.
    Eide PW; Cekaite L; Danielsen SA; Eilertsen IA; Kjenseth A; Fykerud TA; Ågesen TH; Bruun J; Rivedal E; Lothe RA; Leithe E
    Cell Signal; 2013 Jan; 25(1):12-8. PubMed ID: 22974840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
    Tan M; Xu J; Siddiqui J; Feng F; Sun Y
    Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCF(β-TRCP)-mediated degradation of NEDD4 inhibits tumorigenesis through modulating the PTEN/Akt signaling pathway.
    Liu J; Wan L; Liu P; Inuzuka H; Liu J; Wang Z; Wei W
    Oncotarget; 2014 Feb; 5(4):1026-37. PubMed ID: 24657926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of PTEN degradation and NEDD4-1 E3 ligase activity by Numb.
    Shao C; Li Z; Ahmad N; Liu X
    Cell Cycle; 2017 May; 16(10):957-967. PubMed ID: 28437168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The E3 Ubiquitin Ligase NEDD4-1 Mediates Temozolomide-Resistant Glioblastoma through PTEN Attenuation and Redox Imbalance in Nrf2-HO-1 Axis.
    Chuang HY; Hsu LY; Pan CM; Pikatan NW; Yadav VK; Fong IH; Chen CH; Yeh CT; Chiu SC
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ezrin-radixin-moesin-binding phosphoprotein-50 regulates EGF-induced AKT activation through interaction with EGFR and PTEN.
    Zheng J; Dai Y; Yang Z; Yang L; Peng Z; Meng R; Xiong Y; He J
    Oncol Rep; 2016 Jan; 35(1):530-7. PubMed ID: 26531778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTX3 gene activation in EGF-induced head and neck cancer cell metastasis.
    Chang WC; Wu SL; Huang WC; Hsu JY; Chan SH; Wang JM; Tsai JP; Chen BK
    Oncotarget; 2015 Apr; 6(10):7741-57. PubMed ID: 25797258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NEDD4 regulates ubiquitination and stability of the cell adhesion molecule IGPR-1 via lysosomal pathway.
    Sun L; Amraei R; Rahimi N
    J Biomed Sci; 2021 May; 28(1):35. PubMed ID: 33962630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.
    Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM
    Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
    Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
    Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.